123122-55-4
123122-55-4 結(jié)構(gòu)式
基本信息
中文別名
化合物 T10671 英文別名
UK-79300candoxatril
Candoxatril (UK 79300)
Candoxatril [usan:inn:ban]
4α-[[1-[(S)-2-(Indan-5-yloxycarbonyl)-3-(2-methoxyethoxy)propyl]cyclopentan-1-yl]carbonylamino]cyclohexane-1α-carboxylic acid
cis-4-[[[1-[(2S)-3-[(2,3-Dihydro-1H-inden-5-yl)oxy]-2-[(2-Methoxyethoxy)Methyl]-3-oxopropyl]cyclopentyl]carbonyl]aMino]cyclohexanecarboxylic Acid
Cyclohexanecarboxylic acid, 4-[[[1-[(2S)-3-[(2,3-dihydro-1H-inden-5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]-,cis-
物理化學(xué)性質(zhì)
熔點(diǎn)107-109°
比旋光度D -5.8° (c = 1 in methanol)
沸點(diǎn)718.4±60.0 °C(Predicted)
密度1.21±0.1 g/cm3(Predicted)
儲(chǔ)存條件-20°C儲(chǔ)存
溶解度溶于二甲基亞砜
酸度系數(shù)(pKa)4.84±0.25(Predicted)
形態(tài)Solid
顏色White to off-white
常見問題列表
生物活性
Candoxatril 是中性肽鏈內(nèi)切酶 (NEP) 的一個(gè)抑制劑。靶點(diǎn)
NEP.
體內(nèi)研究
While the NEP inhibitors have no significant effect on body weight, food and water intake, mean blood pressure or creatinine levels, they do increase cGMP levels in the urine and affected hematopoiesis in an anti-inflammatory way. Moreover, a-SMA deposition in the kidney cortex is inversely correlated with cGMP elevation suggesting a NEP dependent antifibroti effect. High quality mRNA profiles are obtained with at least 8 independent samples per treatment group. The data confirms the cGMP dependent anti-fibrotic action of Sol-1 and further supports the potential therapeutic actions of this neutral endopeptidase inhibitor.